©
Shutterstock
Image courtesy of Shutterstock
The Global Burden of Disease AMR (GBD AMR) project will gather and publish data on the impact of superbugs globally. Allowing scientists to, for the first time, map disease and death caused by drug-resistant infections, which will be critical in targeting global efforts.
The collaboration was announced today, at the Wellcome Trust’s international Call to Action conference in Berlin, which supports increased action on tackling drug-resistant infection.
Scientists from the Big Data Institute and the Centre for Tropical Medicine and Global Health both at the University of Oxford, and researchers at the Institute for Health Metrics and Evaluation (IHME) University of Washington, will work together on the initiative, intended to increase global awareness and drive support for strategies that can reduce superdrugs. Other key contributors include the Wellcome Trust, and the Bill and Melinda Gates Foundation.